top of page

MENU

Brucellosis in Indian Dairy Herds: The Silent Economic Drain and the Testing Gap

Joshna Bora
5 hours ago
9 min read

Brucellosis is an endemic disease of cattle and buffaloes in India. It is not always observed as infected animals will appear healthy. Losses are caused by abortions during late pregnancy, infertility, increased calving intervals, decreased total milk production, and early culling. It can also be transmitted to humans hence it is a zoonotic disease. The reason is due to drinking raw milk and direct transmission while the animal is giving birth/aborting. This puts all people working on farms (farm workers, vets, insemination technicians) at risk.


The control problem is not that brucellosis is unknown. It is that the animals carrying it are hard to identify, and in a herd vaccinated under a national program, the most widely used screening methods become harder to interpret, not easier. This article covers the economic reality, why identification is difficult, and where nucleic acid screening fits.


Key points

  • Brucellosis is prevalent in India, caused mainly by Brucella abortus in cattle and buffaloes, as well as B. melitensis in small ruminants. (Source: ICAR, NIVEDI, NCBI)

  • Economic losses to Indian livestock due to bovine brucellosis has been estimated to be in the billions of US dollars annually. (Singh et al., Economic losses occurring due to brucellosis in Indian livestock populations, 2015)

  • It is a reportable disease that is controlled by the states. It is part of the national animal disease control programme in India and mass calf vaccinations are used to control the disease. (Source: PIB, Gov of India)

  • Vaccinations make antibody based screening difficult. Animals vaccinated with the standard live vaccine can display similar antibody responses to animals that are infected.

  • Animals typically show no signs of infection between breeding periods. There is no reliable clinical sign to screen for.

  • Occupational zoonosis acquired from consuming unpasteurised milk.

  • In humans, brucellosis can often be mis-diagnosed as other febrile illnesses due to the non-specific relapsing fever symptoms (Source: WHO, CDC)

  • Brucella is a known lab hazard. The culture techniques are a high risk of causing lab acquired infections and should be kept within proper containment.


Fig.: The hidden cost of brucellosis

The Economic Impact

Most often, when asked how much they lose due to brucellosis, dairy owners will say they don’t have brucellosis. However, if you ask them how many abortions they’ve had in the last quarter, how many repeat breeders they have, how many cows have been culled early due to infertility or how much their calving intervals are increasing, then you’ll see some numbers.


This is the key point: the losses are incurred in your reproductive management.


That is the defining commercial feature of this disease: the losses are recorded under reproductive management, not under disease.


The Cost of One Brucellosis-Associated Abortion

A per-animal model for Indian commercial dairy

Note: All values below are illustrative placeholders for a crossbred commercial herd. They are not sourced figures and must not be published as such. Replace each input with your own records or a cited source before this goes anywhere public. The model structure is the deliverable; the numbers are yours to supply.

Cost component

Basis

Input parameter

Illustrative value

Cost 

(₹)

Lost milk, current lactation 

Late-gestation Abortion truncates and suppresses the lactation.

Expected yield: 3,000 L; achieved ~60%; loss: 1,200 L × net margin of ₹12/L

1,200 L × ₹12

14,400 

Lost calf 

No live calf from the pregnancy

Expected calf value, sex-weighted (50% female at ₹18,000; 50% male at ₹2,000), discounted for rearing cost

Expected ₹10,000, taken as

8,000

Treatment

Retained placenta, metritis, veterinary attendance

2–3 vet visits, uterine therapy, antibiotics

— 

3,000

Extended days open

Repeat breeding delays the next lactation.

75 additional open days × ₹100/day maintenance and overhead

75 × ₹100

7,500

Premature culling

A proportion of affected cows are culled early for infertility.

Replacement heifer ₹60,000 − salvage ₹20,000 = ₹40,000 net, × 25% probability 

₹40,000 × 0.25

10,000

TOTAL—one abortion event

₹42,900

Round figure for communication: approximately ₹43,000 per brucellosis-associated abortion.


The zoonotic dimension is an occupational risk, not an abstraction.

Humans can get infected by consuming raw milk and dairy products. Direct contact with birthing secretions, placenta and aborted fetuses also carries a high risk of infection. Farm workers who assist with births, vets, artificial insemination technicians and abattoir workers are at particular risk.

Brucellosis in humans causes undulant fever, joint pain, sweating and tiredness. This can be easily confused with other febrile illnesses that are common within India so the disease is considered to be greatly under diagnosed.

For a commercial dairy operation, this is not only a welfare matter. It is a workforce health exposure attached to a specific, identifiable animal population.


Why identification is the bottleneck

The organism hides.

The organism is a facultative intracellular organism that infects the genital tract and supramammary lymph nodes. The organism can survive within the host cells of the animal, with shedding being intermittent throughout the animal's lifetime. During periods of shedding (around parturition and abortion), the animal will be infected but may be clinically normal for long periods of time.


There is no clinical sign to screen for an analytical method is needed.


Antibody-based. A vaccine interferes with antibodies.

The main issue in any country that implements a mass vaccination programme.

The majority of screening tests for brucellosis are antibody based. This is fine if the only cause of antibodies is infection but this is not the case if a national calfhood vaccination programme is in place.

The live vaccine causes an antibody response. When using the standard serological tests this can be problematic as the results will be very similar to that of a naturally infected animal. This means animals showing a positive result could be infected or that the vaccine has been successful.

As they are antibody based there is a period of time for antibodies to build up. Recently infected animals may show a negative result.


If an animal from a vaccinated herd shows a positive antibody result this causes confusion for the owner.


Definitive but operational issues.

The gold standard is isolation of the organism but this can be slow. Brucella is a fastidious organism and cultures may take a long time to grow. There is also a real biosafety issue. Brucella is one of the most commonly reported causes of laboratory acquired infections worldwide. Therefore it must be handled by trained personnel with suitable containment.


These factors make it unsuitable for routine herd screening. Only a few samples will be tested and this will be long after the decision making period.


Bulk milk screening is herd-level only.

Bulk milk screening can be done at a low cost but only provides herd level information. It doesn't provide information about the individual animal. Vaccination status, mastitis, colostrum and stage of lactation will effect the results. This means interpretation of the results is required to help decide what action to take. It also won't tell you which animals to look at.


Approach

Measures

Herd or animal level

Principal limitation

Clinical observation

Signs

Animal

No reliable sign between reproductive events

Serological screening

Antibodies

Animal

Vaccine-induced response can be indistinguishable from infection; window period

Bulk milk screening

Antibodies in pooled milk

Herd only

Cannot identify individual animals; confounded by vaccination, mastitis, lactation stage

Culture

The organism

Animal

Extended turnaround; significant biosafety requirement

Nucleic acid detection

Organism DNA

Animal or pooled

Detects genetic material present in the sample at the time of testing



What nucleic acid screening changes

Real-time polymerase chain reaction (RT- PCR) is looking at DNA from the organism rather than antibodies from the animal. This solves the issue.


Not influenced by vaccination status. Nucleic acid tests are giving you information about genetic material that is present within your sample. It will not tell you anything about the immune response to the vaccine.


No waiting for seroconversion. Genetic material will be detected without waiting for immune response.


Results are available in a timely manner. The amplification is completed in less than an hour so can be used for screening herds.


What it does not do

Results are not diagnostic. Molecular screening is used as a tool to identify samples that need to be taken further. Confirmation, statutory notification and any decisions at a herd level will be done using the correct veterinary and regulatory processes. The PCR tests for DNA  cannot confirm viability of the organism.



The Seqlo Brucella Detection Kit

Seqlo manufactures real-time PCR-based kits for food, dairy and livestock applications. The Brucella Detection Kit is designed for rapid identification of Brucella spp. in dairy products, food products, meat, and cosmetic products.

Specification

Detail

Target

Brucella spp. genus level

Sample compatibility

Milk , fetal tissue, semen, urine, whole blood, cultured cells and tissue

PCR run time

65 minutes (amplification stage; total time to result excluded DNA extraction)

Chemistry

SYBR Dye-based

Fluorescence channel

SYBR / FAM

Data type

Qualitative

Platform

Seqlo RT PCR System

Catalogue/pack

DSS-BRC-011 / 100 reactions


Interpretation of results

Brucella specific primers were used and therefore if there is a crossing point on the threshold line and an amplification curve with the correct melting curve profile then this indicates a positive sample. The negative control will not show any amplification.

The melting curve is important here. As it is a dye based system the fluorescent signal will indicate that there is double stranded DNA present. The melting curve will confirm that this is the correct amplicon and not a non-specific product. This is due to specific primer design which has been confirmed via the melting profile. The negative control will confirm that the run was clean.




                                           Fig.: Amplification peak for the brucella 

Operational fit

The small and robust design with single operator use allows screening to be carried out outside the central laboratory. This could be at a co-operative collection point, large commercial farm or district veterinary site. The results are then available through the web based reporting system, allowing a Veterinary Officer/Quality Head to view the screening data from multiple sites.


Where screening fits in a herd Health Programme

Screening is only useful if it changes a decision. Four points where it does:

Incoming animal screening. Purchased animals are the most common route by which brucellosis enters a clean herd. Screening before introduction is the single highest-value application.

Investigate reproductive losses. Abortion(s), especially if occurring in the latter half of pregnancy. Especially if abortions occur in clusters.

Regular herd health monitoring. Ensure you have some form of records to show the status of your herd. Particularly important if you supply institutional buyers or breeding.


Bulk milk testing. A cheap initial screening tool. Sample bulk milk to detect issues. If required sample individuals.


In every case, the screening result is an indicator that directs veterinary attention, not a verdict. Confirmation and any subsequent action follow the prescribed pathway.


Evidence based Herd Development

Brucellosis can be the largest cost in an Indian dairy herd due to lack of identification. This can be seen across many areas such as abortions, rebreeding, long calving intervals and premature culling.

Seqlo have real time PCR based screening solutions with small footprint instruments that can be used for testing livestock and dairy samples from a central lab to reception or farm.

From a farm or commercial herd management perspective we can show you how the screening process would work within your incoming animals and breeding loss investigation. From a laboratory perspective we can show you what capacity, workflow and sample costs would look like. From a co-operative or reception perspective we can show you how a pooling strategy would work across your sample points.


Let us know how large your herd is, your sampling strategy and how you are currently screening. We can develop a workflow for you.



Frequently Asked Questions


Q: What is Brucellosis in Cattle?

A: Brucellosis is a bacterial infection mainly caused by Brucella abortus. It affects the genital tract and causes late abortion, placenta retention, rebreeding and low fertility in cattle and buffaloes. The animal will generally look healthy between breeding periods but remains a carrier for life.


Q: How is brucellosis transmitted?

A: Mainly by coming into contact with birthing discharges, placentae and aborted foetuses which have very high levels of bacteria. Brucellosis can also be transferred via infected feed, water and bedding. The disease can be passed from dam to calf in milk. The main way brucellosis enters a clean herd is by buying in new stock.


Q: Is brucellosis an animal to human disease?

A: Yes, it is a zoonotic disease. Transmission routes include consumption of unpasteurised milk/dairy products. Direct transmission can occur through contact with birth products and abortions. Those at highest risk include farm workers, vets, insemination technicians and abattoir workers.


Q: Why is brucellosis so hard to find in vaccinated herds?

A: Most screening tests for brucellosis are antibody based. The live vaccine causes antibody production which can give a false positive result using commonly used serum diagnostic tests. This can make it very difficult to differentiate between vaccination and infection. Using tests that look for genetic material allows us to find the actual organism.


Q: How is PCR used for brucellosis screening?

A: Real time PCR is used to detect Brucella genetic material within a sample. Species specific primers are used and amplification is seen by measuring fluorescent signal throughout the cycles. Melt curves are used to confirm that the correct product has been amplified. Amplification can be completed within an hour.


 
 
 

Comments


bottom of page